Skip to main content

Cardiac Pharmacology

  • Chapter
  • First Online:
Cardiac Emergencies in Children

Abstract

Pharmacologic therapy is fundamental to the treatment of cardiac emergencies in children. Unfortunately, as with most drug therapy in children, little data exists as to optimal application of therapeutic agents. Therefore, a sound understanding of developmental physiology and pharmacology is necessary. In this chapter, we offer a succinct review of developmental physiology and pharmacology relevant to drug therapy and a concise overview of the application of the most relevant drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Allen HD. Moss and Adams heart disease in infants, children, and adolescents: including the fetus and young adult, vol. 2. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013.

    Google Scholar 

  2. Guyton AC, Hall JE. Textbook of medical physiology, vol. xxxv. 11th ed. Philadelphia: Elsevier Saunders; 2006. 1116 p

    Google Scholar 

  3. Katz AM, Smith VE. Regulation of myocardial function in the normal and diseased heart. Modification by inotropic drugs. Eur Heart J. 1982;3 Suppl D:11–8.

    CAS  PubMed  Google Scholar 

  4. Ghali MGZ. Role of the medullary lateral tegmental field in sympathetic control. J Integr Neurosci. 2017;16(2):189–208.

    Article  Google Scholar 

  5. Cody RJ. The integrated effects of angiotensin II. Am J Cardiol. 1997;79(5A):9–11.

    Article  CAS  Google Scholar 

  6. Takayama Y, Costa KD, Covell JW. Contribution of laminar myofiber architecture to load-dependent changes in mechanics of LV myocardium. Am J Physiol Heart Circ Physiol. 2002;282(4):H1510–20.

    Article  CAS  Google Scholar 

  7. Adhyapak SM, Parachuri VR. Architecture of the left ventricle: insights for optimal surgical ventricular restoration. Heart Fail Rev. 2010;15(1):73–83.

    Article  Google Scholar 

  8. Robinson RB. Autonomic receptor--effector coupling during post-natal development. Cardiovasc Res. 1996;31 Spec No:E68–76.

    Article  CAS  Google Scholar 

  9. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89(4):330–5.

    Article  Google Scholar 

  10. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(25):2462–3.

    CAS  PubMed  Google Scholar 

  11. Kho TL, et al. Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction. Eur J Clin Pharmacol. 1980;18(3):213–7.

    Article  CAS  Google Scholar 

  12. Jaski BE, et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J Clin Invest. 1985;75(2):643–9.

    Article  CAS  Google Scholar 

  13. Hoffman TM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107(7):996–1002.

    Article  CAS  Google Scholar 

  14. De Luca L, et al. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006;27(16):1908–20.

    Article  Google Scholar 

  15. Ignarro LJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218(3):739–49.

    CAS  PubMed  Google Scholar 

  16. Overholt ED, et al. Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol. 1988;61(4):336–40.

    Article  CAS  Google Scholar 

  17. Reynolds RD, Gorczynski RJ, Quon CY. Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol. 1986;26 Suppl A:A3–A14.

    Article  CAS  Google Scholar 

  18. Singh BN. Amiodarone: historical development and pharmacologic profile. Am Heart J. 1983;106(4 Pt 2):788–97.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeff Clark M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Clark, J., Tilford, B. (2018). Cardiac Pharmacology. In: Sarnaik, A., Ross, R., Lipshultz, S., Walters III, H. (eds) Cardiac Emergencies in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-73754-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-73754-6_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-73753-9

  • Online ISBN: 978-3-319-73754-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics